• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用定量 PCR 技术对生长抑素受体亚型表达谱进行分析,并与胰腺内分泌肿瘤的临床病理特征相关性研究。

Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors.

机构信息

Departments of Pathology and Molecular Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

出版信息

Pancreas. 2010 Nov;39(8):1147-54. doi: 10.1097/MPA.0b013e3181e78120.

DOI:10.1097/MPA.0b013e3181e78120
PMID:20717067
Abstract

OBJECTIVES

Pancreatic endocrine tumor (PET) presents variable clinical features. Five subtypes of somatostatin receptor (SSTR) are involved in hormone secretion and cell proliferation. In this paper, we explore the correlation between the SSTR subtype messenger RNA (mRNA) expression and clinicopathological features of PET.

METHODS

Twenty-one cases of PET and 5 cases of pancreatic adenocarcinomas (AC) were studied. Using total RNA extracted from paraffin sections and fresh tissues, SSTR subtype mRNA was quantified by real-time polymerase chain reaction. The hormones and MIB1 index were examined using immunohistochemical techniques.

RESULTS

The mRNA levels of SSTR1, SSTR2, SSTR3, and SSTR5 were high in PET compared with AC, whereas the expression of SSTR4 was low in PET and AC. Levels of each subtype did not vary with histological grades. Somatostatin receptor 2 levels in functioning tumors were slightly low compared with nonfunctioning tumors. Four distinct groups of PET were identified by hierarchical cluster analysis, and two of these groups showed reduced SSTR5 with elevation of MIB1 index.

CONCLUSIONS

The study showed a heterogeneous expression profile of SSTR subtype mRNA and the association of reduction in SSTR5 with high proliferative activity. Such profiling of SSTR subtypes may provide useful information on tumor biology and treatment of PET.

摘要

目的

胰腺内分泌肿瘤(PET)表现出多种临床特征。五种生长抑素受体(SSTR)亚型参与激素分泌和细胞增殖。本文探讨了 SSTR 亚型信使 RNA(mRNA)表达与 PET 临床病理特征之间的相关性。

方法

研究了 21 例 PET 病例和 5 例胰腺腺癌(AC)。使用从石蜡切片和新鲜组织中提取的总 RNA,通过实时聚合酶链反应定量 SSTR 亚型 mRNA。使用免疫组织化学技术检测激素和 MIB1 指数。

结果

与 AC 相比,PET 中 SSTR1、SSTR2、SSTR3 和 SSTR5 的 mRNA 水平较高,而 SSTR4 在 PET 和 AC 中的表达较低。各亚型的水平与组织学分级无关。功能性肿瘤中 SSTR2 的水平略低于无功能性肿瘤。通过层次聚类分析,确定了 PET 的四个不同亚群,其中两个亚群表现出 SSTR5 降低和 MIB1 指数升高。

结论

该研究显示 SSTR 亚型 mRNA 表达存在异质性,并发现 SSTR5 减少与高增殖活性相关。这种 SSTR 亚型的分析可能为 PET 的肿瘤生物学和治疗提供有用的信息。

相似文献

1
Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors.采用定量 PCR 技术对生长抑素受体亚型表达谱进行分析,并与胰腺内分泌肿瘤的临床病理特征相关性研究。
Pancreas. 2010 Nov;39(8):1147-54. doi: 10.1097/MPA.0b013e3181e78120.
2
Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.原发性人类乳腺癌中的生长抑素受体:1 - 5型亚型mRNA的定量分析及其与受体蛋白表达和肿瘤病理学的相关性
Breast Cancer Res Treat. 2005 Jul;92(2):175-86. doi: 10.1007/s10549-005-2414-0.
3
Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas.生长抑素受体5型(SSTR5)信使核糖核酸表达与胰岛素瘤细胞增殖的组织病理学特征相关。
Endocr Relat Cancer. 2006 Mar;13(1):69-78. doi: 10.1677/erc.1.00962.
4
Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.生长抑素受体亚型的鉴定及其对生长抑素类似物SMS 201-995治疗人类内分泌肿瘤疗效的影响。
J Clin Invest. 1994 Mar;93(3):1321-5. doi: 10.1172/JCI117090.
5
Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.针对人类生长抑素受体亚型 1-5 的单克隆抗体:在神经内分泌肿瘤中的开发和免疫组织化学应用。
Neuroendocrinology. 2012;95(3):232-47. doi: 10.1159/000330616. Epub 2011 Dec 13.
6
Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.生长抑素受体mRNA在人脑膜瘤中的表达及其在体外抗增殖活性中的意义。
J Neurooncol. 2004 Jan;66(1-2):155-66. doi: 10.1023/b:neon.0000013498.19981.55.
7
Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis.81例胃肠及胰腺内分泌肿瘤中生长抑素受体1 - 5型的表达。一项相关免疫组织化学及逆转录聚合酶链反应分析
Virchows Arch. 2002 May;440(5):461-75. doi: 10.1007/s00428-002-0609-x. Epub 2002 Mar 23.
8
Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.胰腺神经内分泌肿瘤患者生长抑素受体2A免疫组化、逆转录定量聚合酶链反应及体内正电子发射断层扫描/计算机断层扫描数据的分析
Pancreas. 2015 May;44(4):648-54. doi: 10.1097/MPA.0000000000000316.
9
Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.结直肠癌中生长抑素受体亚型表达与临床病理、Ki-67、Bcl-2及p53之间的关系
World J Gastroenterol. 2006 Apr 7;12(13):2011-5. doi: 10.3748/wjg.v12.i13.2011.
10
Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours.⁶⁸Ga-生长抑素受体 PET/CT 分子成像及其与神经内分泌肿瘤生长抑素受体免疫组化的相关性。
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1659-68. doi: 10.1007/s00259-011-1846-5. Epub 2011 May 31.

引用本文的文献

1
Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies.晚期胰腺神经内分泌肿瘤患者接受药物/放射/肝脏靶向抗肿瘤治疗后耐药性疾病的预测因素:最新进展与争议
Cancers (Basel). 2022 Feb 28;14(5):1250. doi: 10.3390/cancers14051250.
2
Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy.生长抑素受体在胰腺神经内分泌肿瘤发生、诊断和治疗中的作用。
Front Endocrinol (Lausanne). 2021 May 19;12:679000. doi: 10.3389/fendo.2021.679000. eCollection 2021.
3
Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells.
表皮生长因子诱导人胰腺神经内分泌肿瘤细胞中功能性生长抑素2型受体上调。
Oncotarget. 2016 May 19;9(19):14791-14802. doi: 10.18632/oncotarget.9462. eCollection 2018 Mar 13.
4
Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20.在Ki67指数高于20的胰腺和胰腺外神经内分泌肿瘤中,生长抑素受体表达与TP53和RB1改变相关。
Mod Pathol. 2017 Apr;30(4):587-598. doi: 10.1038/modpathol.2016.217. Epub 2017 Jan 6.
5
Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors.神经内分泌肿瘤中生长抑素受体表达与临床结局的关联
Pancreas. 2016 Nov;45(10):1386-1393. doi: 10.1097/MPA.0000000000000700.
6
mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer.生长抑素受体亚型SSTR - 2、SSTR - 3和SSTR - 5的mRNA表达及其在胰腺癌中的意义。
World J Surg Oncol. 2015 Feb 13;13:46. doi: 10.1186/s12957-015-0467-z.
7
Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors.胃抑制多肽受体(GIPR)是神经内分泌肿瘤成像和治疗的一个有前途的靶点。
Surgery. 2013 Dec;154(6):1206-13; discussion 1214. doi: 10.1016/j.surg.2013.04.052.
8
Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.胃肠道神经内分泌肿瘤原发灶和转移灶中膜蛋白的过度表达。
Ann Surg Oncol. 2013 Dec;20 Suppl 3(0 3):S739-S746. doi: 10.1245/s10434-013-3318-6. Epub 2013 Oct 10.
9
Characterization of neuroendocrine tumors of the pancreas by real-time quantitative polymerase chain reaction. A methodological approach.应用实时定量聚合酶链反应对胰腺神经内分泌肿瘤进行特征分析。一种方法学研究。
Endocr Pathol. 2013 Jun;24(2):83-91. doi: 10.1007/s12022-013-9246-y.
10
EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience.超声内镜引导下细针穿刺活检用于胰腺神经内分泌肿瘤:一家三级癌症中心的经验。
Dig Dis Sci. 2012 Mar;57(3):791-800. doi: 10.1007/s10620-011-1912-7. Epub 2011 Oct 1.